RapidAI is the worldwide leader in advanced imaging for stroke. Based on intelligence gained over 1,000,000 scans from more than 1,600 hospitals in over 50 countries, the Rapid® platform uses artificial intelligence to create high quality, advanced images from non-contrast CT, CT angiography, CT perfusion, and MRI diffusion and perfusion scans. The Rapid imaging platform includes Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, and Rapid MRI. RapidAI also offers SurgicalPreview, a comprehensive aneurysm management platform.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/17/20 | $25,000,000 | Series B |
Lennertz & Co. | undisclosed |
| 07/27/23 | $75,000,000 | Series C |
Vista Credit Partners | undisclosed |
